Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects: L-arginine-induced vasodilatation cannot be explained by non-specific effects of cationic amino acids

Clinical Science

Volumn 92, Issue 4, 1997, Pages 367-374

  Smulders, R A ^a,b   Aarsen, M ^a   Teerlink, T ^a   De Vries, P M J M ^a   Van Kamp, G J ^a   Donker, A J M ^a   Stehouwer, C D A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

L arginine; L lysine; Nitric oxide

Indexed keywords

AMINO ACID; ARGININE; ATRIAL NATRIURETIC FACTOR; CITRULLINE; CYCLIC GMP; LYSINE; NITRIC OXIDE; POTASSIUM;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; ELECTROLYTE BLOOD LEVEL; ENDOTHELIUM; EXTRACELLULAR SPACE; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PLASMA OSMOLALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND MESSENGER; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL; UREA CYCLE; VASCULAR RESISTANCE; VASODILATATION;

EID: 0030941152     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920367     Document Type: Article

References (38)

1. Vane JR, Änggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-35.
2. Shepherd JT, Katusic ZS. Endothelium-derived vasoactive factors: I. Endothelium-dependent relaxation. Hypertension 1991; 18 (Suppl III): 76-85.
3. Lüscher TF, Boulanger CM, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension 1992; 19: 117-30.
4. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
5. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.
6. Calver AI, Collier JG, Moncada S, Vallance PJT. Effect of local intra-arterial N-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025-31.
7. Katz SD, Schwarz M, Yuen J, Lejemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 1993; 88: 55-61.
8. Calver AI, Collier JG, Vallance PJT. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90: 2548-54.
9. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993; 88: 2510-16.
10. Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993; 85: 687-93.
11. Creager M, Cooke J, Mendelsohn M, Gallagher S, Coleman S, Loscalzo J, Dzau V. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-34.
12. Chowienczyk P, Watts G, Cockcroft J, Ritter J. Impaired endothelium-dependent vasodilatation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340: 1430-2.
13. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990; 30: 535-60.
14. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
15. Imaizumi T, Hirooka Y, Masaki H, Harada S, Momohara M, Tagawa T, Takeshita A. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992; 20: 511-7.
16. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R. L-Arginine-induced hypotension. Lancet 1990; 336: 696.
17. Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R. L-Arginine-induced hypotension. Lancet 1991; 337: 683-4.
18. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F. L-Arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992; 19: 619-25.
19. Smulders RA, Stehouwer CDA, Olthof CG, Van Kamp GJ, Teerlink T, De Vries PMJM, Donker AJM. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994; 87: 37-43.
20. Bode-Böger S, Böger R, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frölich J. L-Arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994; 87: 303-10.
21. Castillo L, DeRojas T, Chapman T, Vogt J, Burke J, Tannenbaum S, Young V. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci USA 1993; 90: 193-7.
22. Kharitonov S, Lubec G, Lubec B, Hjelm M, Barnes P. L-Arginine increases exhaled nitric oxide in normal human subjects. Clin Sci 1995; 88: 135-9.
23. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. J Parenter Enteral Nutr 1985; 10: 227-38.
24. Kouw PM, De Vries PMJM, Donker AJM. Non-invasive measurement of body fluid dynamics. In: Andreucci VE, Fine LG, eds. International Yearbook of Nephrology 1993. London: Springer-Verlag, 1992: 333-51.
25. Olthof CG, De Vries PMJM, Kouw PM, Oe PL, Schneider H, De Lange JJ, Donker AJM. A non-invasive conductivity method for the detection of dynamic body fluid change: in vitro and in vivo validation. Nephrol Dial Transplant 1993; 8: 41-6.
26. Woltjer HH, Arntzen BWGJ, Bogaard HJ, De Vries PMJM. Optimalization of the spot electrode array in impedance cardiography. Med Biol Eng Comput 1995; 34: 1-4.
27. Kubicek WG, Karnegis, JN, Patterson RP, Witsoe DA, Mattson, R.H. Development and evaluation of an impedance cardiac output system. Aerospace Med 1966; 37: 1208-12.
28. Teerlink T, Leeuwen P, Houdijk A. Plasma amino acids determined by liquid chromatography within 17 minutes. Clin Chem 1994; 40: 245-9.
29. Bland J, Altman D. Calculating correlation coefficients with repeated observations: Part I Correlation within subjects. Br Med J 1995; 310: 446.
30. Calver AI, Collier JG, Vallance PJT. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991; 81: 695-700.
31. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87: 1475-81.
32. MacAllister R, Calver A, Collier J, Edwards C, Herreros B, Nussey S, Vallance P. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci 1995; 89: 183-90.
33. Floyd J, Fajans S, Conn J, Knopf R, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 1966; 45: 1487-502.
34. White MF. The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochem Biophys Acta 1985; 822: 355-75.
35. Massara F, Martelli S, Cagliero E, Molinatti G. The hypophosphatemic and hyperkalemic effect of arginine in man. J Endocrinol Invest 1980; 3: 177-80.
36. Anderson EA, Mark AL. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension 1993; 21: 136-41.
37. Rhodes P, Barr CS, Struthers AD. Arginine, lysine and ornithine as vasodilators in the forearm of man. Eur J Clin Invest 1996; 26: 325-31.
38. Trovati M, Massucco P, Mattiello L, Cavalot F, Mularoni E, Hahn A, Anfossi G. Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetologia 1995; 38: 936-41.